ENTRADA THERAPEUTICS INC(NASDAQ:TRDA) stock Analyst Ratings

Buy % Consensus

ChartMill assigns a Buy % Consensus number of 85% to TRDA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 24.82. This target is 197.96% above the current price.

TRDA was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about TRDA.

In the previous month the buy percentage consensus was at a similar level.

TRDA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price

Low

Median

Mean

High

8.33

20.20

23.46

24.82

31.50

142.50%

181.63%

197.96%

278.15%

Up and Down Grades

Date	Firm	Action	Rating
2025-03-31	HC Wainwright & Co.	Reiterate	Buy -> Buy
2025-02-25	HC Wainwright & Co.	Reiterate	Buy -> Buy
2025-02-04	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-12-05	Roth MKM	Initiate	Buy
2024-11-06	Oppenheimer	Maintains	Outperform -> Outperform
2024-11-06	HC Wainwright & Co.	Maintains	Buy -> Buy
2024-08-26	Oppenheimer	Reiterate	Outperform -> Outperform
2024-08-14	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-06-25	HC Wainwright & Co.	Maintains	Buy -> Buy
2024-03-18	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-01-05	Oppenheimer	Initiate	Outperform
2023-11-27	HC Wainwright & Co.	Maintains	Buy -> Buy
2023-09-22	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-08-09	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-08-02	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-05-24	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-04-03	HC Wainwright & Co.	Initiate	Buy
2022-11-08	Goldman Sachs	Maintains	Neutral
2022-08-16	Goldman Sachs	Maintains	Neutral
2022-05-24	Goldman Sachs	Maintains	Neutral
2021-11-24	Evercore ISI Group	Initiate	Outperform
2021-11-23	Cowen & Co.	Initiate	Outperform
2021-11-23	Goldman Sachs	Initiate	Neutral

ENTRADA THERAPEUTICS INC (TRDA) Stock Analyst Ratings